Naproxcinod Can Win Approval Without Superiority Trial, NicOx Says
Facing skeptical FDA, company in partnering talks as more Phase III data with anti-inflammatory drug prove positive.
Facing skeptical FDA, company in partnering talks as more Phase III data with anti-inflammatory drug prove positive.